Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Serum 25(OH)D was significantly lower in PCOS women compared to fertile controls (mean 25(OH)D of 49.0 nmol/l versus 64.5 nmol/l).

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cross-sectional study.

Cross-sectional study

Examines a population at a particular point in time.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Vitamin D and metabolic disturbances in polycystic ovary syndrome (PCOS): A cross-sectional study

Source: Article title.

Women were excluded if the blood draw was not performed in a fasting state.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Vitamin D and metabolic disturbances in polycystic ovary syndrome (PCOS): A cross-sectional study

Cross-sectional study · PLoS ONE · 2018

Original publication title

Vitamin D and metabolic disturbances in polycystic ovary syndrome (PCOS): A cross-sectional study

Y. H. M. Krul-Poel; P. P. Koenders; R. P. Steegers-Theunissen; E. ten Boekel; M. M. ter Wee; Y. Louwers; P. Lips; J. S. E. Laven; S. Simsek

© 2018 Krul-Poel et al

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

This study demonstrates that women with PCOS have a significantly lower serum 25(OH)D compared to fertile controls. A compromised vitamin D status in PCOS women is associated with a higher HOMA-IR and an unfavourable lipid profile. Large randomized controlled trials are necessary to explore the causality of this linkage.

An extract from the source publication. Read it in context.

At a glance

Abstract: What objectives does the paper state?

To compare vitamin D status in women with PCOS versus fertile women and subsequently evaluate the association between vitamin D status and metabolic disturbances in PCOS women.

Source: Objective

Abstract: What methods does the paper describe?

We conducted a cross-sectional comparison study of 639 women with PCOS and 449 fertile women. Serum 25-hydroxyvitamin D (25(OH)D) was stratified into a severe deficient (< 25 nmol/l), insufficient (25 to 50 nmol/l), moderate (50 to 75 nmol/l) and adequate (> 75 nmol/l) status. The main outcome measures were the difference in vitamin D status between PCOS and fertile women, and the association between serum 25(OH)D and metabolic disturbances in PCOS women only.

Source: Methods

Abstract: Results

Serum 25(OH)D was significantly lower in PCOS women compared to fertile controls (mean 25(OH)D of 49.0 nmol/l versus 64.5 nmol/l). An adjusted significant difference was seen between serum 25(OH)D and homeostasis model assessment (HOMA-IR) (β = 0.76; 95% CI: 0.63 to 0.91; p < 0.01), HDL-cholesterol (β = 0.20; 95% CI: 0.05 to 0.60, p < 0.01) and apolipoprotein A1 (β = 26.2; 95% CI: 7.5 to 45.0, p < 0.01) between the highest vitamin D group compared to the lowest vitamin D group.

Source: Results

Abstract: Conclusions

This study demonstrates that women with PCOS have a significantly lower serum 25(OH)D compared to fertile controls. A compromised vitamin D status in PCOS women is associated with a higher HOMA-IR and an unfavourable lipid profile. Large randomized controlled trials are necessary to explore the causality of this linkage.

Source: Conclusions
Authors’ abstract

Objective

To compare vitamin D status in women with PCOS versus fertile women and subsequently evaluate the association between vitamin D status and metabolic disturbances in PCOS women.

Methods

We conducted a cross-sectional comparison study of 639 women with PCOS and 449 fertile women. Serum 25-hydroxyvitamin D (25(OH)D) was stratified into a severe deficient (< 25 nmol/l), insufficient (25 to 50 nmol/l), moderate (50 to 75 nmol/l) and adequate (> 75 nmol/l) status. The main outcome measures were the difference in vitamin D status between PCOS and fertile women, and the association between serum 25(OH)D and metabolic disturbances in PCOS women only.

Results

Serum 25(OH)D was significantly lower in PCOS women compared to fertile controls (mean 25(OH)D of 49.0 nmol/l versus 64.5 nmol/l). An adjusted significant difference was seen between serum 25(OH)D and homeostasis model assessment (HOMA-IR) (β = 0.76; 95% CI: 0.63 to 0.91; p < 0.01), HDL-cholesterol (β = 0.20; 95% CI: 0.05 to 0.60, p < 0.01) and apolipoprotein A1 (β = 26.2; 95% CI: 7.5 to 45.0, p < 0.01) between the highest vitamin D group compared to the lowest vitamin D group.

Conclusions

This study demonstrates that women with PCOS have a significantly lower serum 25(OH)D compared to fertile controls. A compromised vitamin D status in PCOS women is associated with a higher HOMA-IR and an unfavourable lipid profile. Large randomized controlled trials are necessary to explore the causality of this linkage.

Publication and source details

Original title: Vitamin D and metabolic disturbances in polycystic ovary syndrome (PCOS): A cross-sectional study

Y. H. M. Krul-Poel; P. P. Koenders; R. P. Steegers-Theunissen; E. ten Boekel; M. M. ter Wee; Y. Louwers; P. Lips; J. S. E. Laven; S. Simsek

PLoS ONE · 2018

Competing Interests: JSE has received research grants from the following pharmaceutical companies (in alphabetical order): Ferring, Merck Serono, Merck Sharpe and Dome, Organon, Shering Plough and Serono. This does not alter our adherence to PLOS ONE policies on sharing data and materials.

* E-mail: s.simsek@nwz.nl (SS); y.krul@vumc.nl (YKP)
© 2018 Krul-Poel et al2018Krul-Poel et alhttps://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.corporate development international2005Laven J. S. E. netherlands heart foundation2002.B027Steegers-Theunissen R. P. The HAVEN study was financially supported by Corporate Development International (grant 2005) and the Netherlands Heart Foundation (grant 2002.B027). Although Prof. J.S.E. Laven received funding from commercial sources: Corporate Development International, Ferring, Merck Serono, Merck Sharpe and Dome, Organon, Shering Plough and Serono, this does not have any influence on the publication of this manuscript.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T20:37:33.401153+00:00

DOI: 10.1371/journal.pone.0204748 · PMC6279035